Trial Details

COMPLETED
Basic Information
Clinical ID c57
Identifier NCT06269185
Trial Title Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Inflammatory Bowel Diseases
Interventions DRUG: Infliximab|DRUG: Adalimumab
Participant Information
Sponsor Vastra Gotaland Region
City Göteborg
Country/Region Sweden
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2024-03-06
Primary Completion Date 2024-10-18
Completion Date 2024-10-18